470 related articles for article (PubMed ID: 21906804)
21. Lipid coated mesoporous silica nanoparticles as photosensitive drug carriers.
Yang Y; Song W; Wang A; Zhu P; Fei J; Li J
Phys Chem Chem Phys; 2010 May; 12(17):4418-22. PubMed ID: 20407714
[TBL] [Abstract][Full Text] [Related]
22. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications.
Lee JE; Lee N; Kim T; Kim J; Hyeon T
Acc Chem Res; 2011 Oct; 44(10):893-902. PubMed ID: 21848274
[TBL] [Abstract][Full Text] [Related]
23. Cellular uptake mechanism and knockdown activity of siRNA-loaded biodegradable DEAPA-PVA-g-PLGA nanoparticles.
Benfer M; Kissel T
Eur J Pharm Biopharm; 2012 Feb; 80(2):247-56. PubMed ID: 22085653
[TBL] [Abstract][Full Text] [Related]
24. Magnetic Core-Shell Silica Nanoparticles with Large Radial Mesopores for siRNA Delivery.
Xiong L; Bi J; Tang Y; Qiao SZ
Small; 2016 Sep; 12(34):4735-42. PubMed ID: 27199216
[TBL] [Abstract][Full Text] [Related]
25. Adsorption and desorption behaviors of DNA with magnetic mesoporous silica nanoparticles.
Li X; Zhang J; Gu H
Langmuir; 2011 May; 27(10):6099-106. PubMed ID: 21488610
[TBL] [Abstract][Full Text] [Related]
26. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
[TBL] [Abstract][Full Text] [Related]
27. Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice.
Huh MS; Lee SY; Park S; Lee S; Chung H; Lee S; Choi Y; Oh YK; Park JH; Jeong SY; Choi K; Kim K; Kwon IC
J Control Release; 2010 Jun; 144(2):134-43. PubMed ID: 20184928
[TBL] [Abstract][Full Text] [Related]
28. Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin.
Ma X; Teh C; Zhang Q; Borah P; Choong C; Korzh V; Zhao Y
Antioxid Redox Signal; 2014 Aug; 21(5):707-22. PubMed ID: 23931896
[TBL] [Abstract][Full Text] [Related]
29. Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles--opportunities & challenges.
Rosenholm JM; Sahlgren C; Lindén M
Nanoscale; 2010 Oct; 2(10):1870-83. PubMed ID: 20730166
[TBL] [Abstract][Full Text] [Related]
30. Influence of protein corona on the transport of molecules into cells by mesoporous silica nanoparticles.
Paula AJ; Araujo Júnior RT; Martinez DS; Paredes-Gamero EJ; Nader HB; Durán N; Justo GZ; Alves OL
ACS Appl Mater Interfaces; 2013 Sep; 5(17):8387-93. PubMed ID: 23841723
[TBL] [Abstract][Full Text] [Related]
31. Enhanced gene delivery by polyethyleneimine coated mesoporous silica nanoparticles.
Zarei H; Kazemi Oskuee R; Hanafi-Bojd MY; Gholami L; Ansari L; Malaekeh-Nikouei B
Pharm Dev Technol; 2019 Jan; 24(1):127-132. PubMed ID: 29357725
[TBL] [Abstract][Full Text] [Related]
32. Cationic drug-derived nanoparticles for multifunctional delivery of anticancer siRNA.
Chang RS; Suh MS; Kim S; Shim G; Lee S; Han SS; Lee KE; Jeon H; Choi HG; Choi Y; Kim CW; Oh YK
Biomaterials; 2011 Dec; 32(36):9785-95. PubMed ID: 21937102
[TBL] [Abstract][Full Text] [Related]
33. Sustained delivery of siRNA/mesoporous silica nanoparticle complexes from nanofiber scaffolds for long-term gene silencing.
Pinese C; Lin J; Milbreta U; Li M; Wang Y; Leong KW; Chew SY
Acta Biomater; 2018 Aug; 76():164-177. PubMed ID: 29890267
[TBL] [Abstract][Full Text] [Related]
34. Enhanced endosomal escape of siRNA-incorporating hybrid nanoparticles from calcium phosphate and PEG-block charge-conversional polymer for efficient gene knockdown with negligible cytotoxicity.
Pittella F; Zhang M; Lee Y; Kim HJ; Tockary T; Osada K; Ishii T; Miyata K; Nishiyama N; Kataoka K
Biomaterials; 2011 Apr; 32(11):3106-14. PubMed ID: 21272932
[TBL] [Abstract][Full Text] [Related]
35. A magnetic, reversible pH-responsive nanogated ensemble based on Fe3O4 nanoparticles-capped mesoporous silica.
Gan Q; Lu X; Yuan Y; Qian J; Zhou H; Lu X; Shi J; Liu C
Biomaterials; 2011 Mar; 32(7):1932-42. PubMed ID: 21131045
[TBL] [Abstract][Full Text] [Related]
36. Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs.
Xia T; Kovochich M; Liong M; Meng H; Kabehie S; George S; Zink JI; Nel AE
ACS Nano; 2009 Oct; 3(10):3273-86. PubMed ID: 19739605
[TBL] [Abstract][Full Text] [Related]
37. Investigation of siRNA-loaded polyethylenimine-coated human serum albumin nanoparticle complexes for the treatment of breast cancer.
Abbasi S; Paul A; Prakash S
Cell Biochem Biophys; 2011 Nov; 61(2):277-87. PubMed ID: 21556941
[TBL] [Abstract][Full Text] [Related]
38. Intracellular cleavable poly(2-dimethylaminoethyl methacrylate) functionalized mesoporous silica nanoparticles for efficient siRNA delivery in vitro and in vivo.
Lin D; Cheng Q; Jiang Q; Huang Y; Yang Z; Han S; Zhao Y; Guo S; Liang Z; Dong A
Nanoscale; 2013 May; 5(10):4291-301. PubMed ID: 23552843
[TBL] [Abstract][Full Text] [Related]
39. Efficient siRNA delivery to mammalian cells using layered double hydroxide nanoparticles.
Ladewig K; Niebert M; Xu ZP; Gray PP; Lu GQ
Biomaterials; 2010 Mar; 31(7):1821-9. PubMed ID: 19922997
[TBL] [Abstract][Full Text] [Related]
40. The promotion of human malignant melanoma growth by mesoporous silica nanoparticles through decreased reactive oxygen species.
Huang X; Zhuang J; Teng X; Li L; Chen D; Yan X; Tang F
Biomaterials; 2010 Aug; 31(24):6142-53. PubMed ID: 20510446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
